login
Home / Papers / Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression...

Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels

DOI: 10.1126/sciadv.abi7511Semantic Scholar
29 Citations•2021•
I. Kurth, N. Yamaguchi, Celia Andreu-Agullo
Science Advances

No TL;DR found

Abstract

RGX-202, a small-molecule creatine transporter SLC6A8 inhibitor, suppresses colorectal cancer and modulates human creatine levels.